Bevacizumab, Radiotherapy and Temozolomide Safety study in resected and irresectable primary GBM patients.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2016
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Biomarker
- Acronyms BERTES
- 30 Jan 2016 Status changed from recruiting to completed.
- 12 Jul 2011 New trial record